Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vaginal therapies for atrophic vaginitis in postmenopausal women with estrogen receptor-positive breast cancer taking Arimidex
ACTRN12609000154202Phase 4Terminated
- Sponsor
- School of Women's and Infants' Health
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol, estriol, polycarbophil vaginal moisturizer and anastrozole in atrophic vaginitis (3 arms), sponsored by School of Women's and Infants' Health. Primary endpoint: Change in serum estradiol levels over 12 weeks. Started Feb 2009; status: terminated.
02
Drugs
estradiolestriolpolycarbophil vaginal moisturizeranastrozole
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on ACTRN12609000154202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000154202.